WYMM Tour: Seattle
WYMM Tour: Seattle
February 14, 2024, 9:00 - 4:00 pm PST - Seattle, Washington, United States
Generate ultra-rich data for answers with impact.
Who says you can’t see it all? With a comprehensive view of structural variants and methylation, nanopore technology powers the bigger and bolder research questions you’ve always wanted to ask.
Join us on Wednesday, February 14th, 2024 in Kane Hall at The University of Washington to hear from local experts who are breaking new ground in human genomics, using nanopore technology.
What you're missing matters. Stay on top of what's next.
Aside from talks ranging from human genomics for rare disease, to sequencing for cancer research, the full-day agenda will include networking breaks, Q&A, product displays, and opportunities to engage with your peers and nanopore experts.
Please note that this is an in-person event.
There is no delegate fee for this event, but registration is required. Lunch and refreshments will be provided. Your place at this event will be confirmed via email from events@nanoporetech.com.
Agenda
9:00 am — 5 :00 pm PT | Agenda (subject to change) | Speaker |
|---|---|---|
9:00 — 9:30 am | Registration/Breakfast | |
9:30 — 9:45 am | Executive welcome | Brian Fritz, Oxford Nanopore Technologies |
9:45 — 10:15 am | What You're Missing Matters - Oxford Nanopore technology introduction | Alan Silverman, Oxford Nanopore Technologies |
10:15 — 10:45 am | Applying long read sequencing to discover rare variants in Mendelian genetics | Karynne Patterson, University of Washington |
10:45 — 11:00 am | Coffee Break | |
11:00 — 11:30 am | Single cell sequencing of B Cells for antibody discovery following MMR vaccination | John Beaulaurier, Oxford Nanopore Technologies |
111:30 am — 12:00 pm | A New Paradigm in Retinal Genetics: Targeted long-read sequencing provides rapid phased variant identification to improve diagnostic yield in Mendelian diseases of the retina | Debarshi Mustafi, University of Washington |
12:00 — 1:00 pm | Lunch | |
1:00 — 1:30 pm | Nanopore sequencing – Insights from neonatal intensive care to cancer | Steven Jones, BC Cancer and University of British Columbia |
1:30 — 2:00 pm | Streamlining testing for individuals with imprinting disorders via long-read sequencing | Cate Paschal, Seattle Children's Hospital |
2:00 — 2:15 pm | Break | |
2:15 — 2:45 pm | What You’re Missing Matters: Nanopore sequencing solutions for biopharma | Indira Medina, Oxford Nanopore Technologies |
2:45 — 3:15 pm | Nanopore sequencing of 1000 Genomes Project samples to identify normal patterns of human variation | Danny Miller, University of Washington |
3:15 — 3:45 pm | Oxford Nanopore Technologies: Tech Update | Mark Bruce, Oxford Nanopore Technologies |
3:45 — 5:00 pm | Closing & Networking |